Clinical Microbiology and Antimicrobial Chemotherapy. 2017; 19(3):208-212
n May 2016, US FDA advised to restrict fluoroquinolones use in patients with acute sinusitis, acute exacerbations of chronic bronchitis, and uncomplicated urinary tract infections. The reason for this decision was the new safety data obtained during …